⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22878265 | 0.76 | — | — | |
| SCHEMBL22878267 | 0.71 | — | — | |
| Isozaluzanin C SCHEMBL17214374 | 0.60 | PKM (0.40) | — | |
| SCHEMBL12109588 | 0.53 | — | — | |
| SCHEMBL9908321 | 0.53 | — | — | |
| SCHEMBL13178737 | 0.53 | — | — | |
| SCHEMBL10054685 | 0.52 | — | — | |
| SCHEMBL13668787 | 0.50 | — | — | |
| SCHEMBL2040443 | 0.50 | — | — | |
| SCHEMBL6741062 | 0.49 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3763419-A1 | CHEMOSENSORY RECEPTOR LIGAND-BASED THERAPIES | Anji Pharma (US) LLC (US) | 2021-01-13 | — | — | EP | disclosed |